Status:
UNKNOWN
Efficacy and Antimicrobial Activity of Platelet Rich Plasma (PRP) in Acne Vulgaris
Lead Sponsor:
Assiut University
Conditions:
Platelet-Rich Plasma
Acne Vulgaris
Eligibility:
All Genders
14-40 years
Phase:
PHASE3
Brief Summary
Efficacy and Antimicrobial activity of Platelet Rich Plasma (PRP) in Acne Vulgaris : A randomized controlled trial
Detailed Description
Acne vulgaris is one of the most common chronic skin diseases worldwide. The condition usually starts in adolescence, peaks at the ages of 14 to 19 years and frequently resolves by mid-twenties. Acne...
Eligibility Criteria
Inclusion
- Patients with active acne vulgaris lesions (inflammatory and non-inflammatory).
- Age range from 14 to 40 years.
- Patients with any topical and systemic treatments will undergo wash out period of one month.
Exclusion
- Patients with herpes labials, or bacterial infection; warts on the face, actinic keratosis, or skin cancer or allergy to medications.
- Systemic retinoids intake in the previous 6 months
- History of keloidal scarring.
- Patients on anticoagulant therapy or aspirin or have a coagulation issue,
- Patients with hemoglobin less than 10g\\dl or platelet less than 105 micron\\l
- Pregnant women
- Immunocompromised patients
- Patients with medical diseases like diabetes mellitus, epilepsy or malignancy
Key Trial Info
Start Date :
January 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 10 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03859843
Start Date
January 10 2020
End Date
May 10 2022
Last Update
March 5 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.